News

Pharmabiz18m
Kairos Pharma reports positive results from phase 2 trial of ENV-105 in advanced prostate cancer
Kairos Pharma reports positive results from phase 2 trial of ENV-105 in advanced prostate cancer: Los Angeles Thursday, July 17, 2025, 15:00 Hrs [IST] Kairos Pharma, Ltd., a clini ...
Pharmabiz33m
HOSMAC inks MoU with Gulf Medical University as industry partner to strengthen healthcare education
HOSMAC inks MoU with Gulf Medical University as industry partner to strengthen healthcare education: Our Bureau, Bengaluru Thursday, July 17, 2025, 14:45 Hrs [IST] HOSMAC, Asia’ ...
Pharmabiz48m
Aethlon Medical announces DSMB completes its scheduled safety review and recommended advancing to the next patient cohort without modification
Aethlon Medical announces DSMB completes its scheduled safety review and recommended advancing to the next patient cohort without modification: San Diego Thursday, July 17, 2025, ...
Pharmabiz1h
Entod Pharma signs MoU with VESCOP to empower young pharma innovators
Entod Pharma signs MoU with VESCOP to empower young pharma innovators: Our Bureau, Mumbai Thursday, July 17, 2025, 14:15 Hrs [IST] Entod Pharmaceuticals Ltd., a global leader in o ...
Pharmabiz1h
Corona Remedies acquires seven brands in cardiology & women’s healthcare from the pharmaceutical division of Bayer in India
Corona Remedies acquires seven brands in cardiology & women’s healthcare from the pharmaceutical division of Bayer in India: Our Bureau, Mumbai Thursday, July 17, 2025, 13:50 Hr ...
Pharmabiz2h
Akeso initiates patient enrolling in phase III trial of ivonescimab for first-line treatment of advanced metastatic colorectal cancer
Akeso initiates patient enrolling in phase III trial of ivonescimab for first-line treatment of advanced metastatic colorectal cancer: Hong Kong Thursday, July 17, 2025, 13:00 Hrs ...
Pharmabiz1h
IDMA partners with JetSynthesys’ Inclusional for its first-ever major PoSH compliance drive
IDMA partners with JetSynthesys’ Inclusional for its first-ever major PoSH compliance drive: Our Bureau, Mumbai Thursday, July 17, 2025, 13:40 Hrs [IST] In a landmark move to sh ...
Pharmabiz1h
WHO includes ArkBio' paediatric RSV drug, ziresovir in PADO-RSV priority list
WHO includes ArkBio' paediatric RSV drug, ziresovir in PADO-RSV priority list: Shanghai, China Thursday, July 17, 2025, 14:00 Hrs [IST] Shanghai Ark Biopharmaceutical Co., Ltd. (A ...
Pharmabiz23h
Reckitt focus on health and hygiene initiatives helps winning Global Health Awards 2025 at House of Commons, London
Reckitt focus on health and hygiene initiatives helps winning Global Health Awards 2025 at House of Commons, London: Our ...
Pharmabiz4h
Senhwa Biosciences begins patient dosing in NCI-sponsored pilot study of Pidnarulex pharmacodynamics in patients with advanced solid tumours
Senhwa Biosciences begins patient dosing in NCI-sponsored pilot study of Pidnarulex pharmacodynamics in patients with advanced solid tumours: Taipei, Taiwan Thursday, July 17, 202 ...
Pharmabiz3h
Iovance Biotherapeutics’ Amtagvi study data shows 49 per cent response rate for commercialisation
Iovance Biotherapeutics’ Amtagvi study data shows 49 per cent response rate for commercialisation: San Carlos, California Thursday, July 17, 2025, 12:00 Hrs [IST] Iovance Biothe ...
Pharmabiz5h
US FDA grants fast track designation to Sanofi’s SAR446597 to treat geographic atrophy due to age-related macular degeneration
US FDA grants fast track designation to Sanofi’s SAR446597 to treat geographic atrophy due to age-related macular degeneration: Paris Thursday, July 17, 2025, 10:00 Hrs [IST] Th ...